Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases (2024)

  • Mahler, M., Meroni, P. L., Bossuyt, X. & Fritzler, M. J. Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J. Immunol. Res. 2014, 315179 (2014).

    PubMed PubMed Central Google Scholar

  • Meroni, P. L. & Schur, P. H. ANA screening: an old test with new recommendations. Ann. Rheum. Dis. 69, 1420–1422 (2010).

    CAS PubMed Google Scholar

  • Aringer, M. et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann. Rheum. Dis. 78, 1151–1159 (2019).

    PubMed Google Scholar

  • Shiboski, C. H. et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann. Rheum. Dis. 76, 9–16 (2017).

    PubMed Google Scholar

  • van den Hoogen, F. et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Ann. Rheum. Dis. 72, 1747–1755 (2013).

    PubMed Google Scholar

  • Alarcon-Segovia, D. & Villareal, M. Classification and diagnostic criteria for mixed connective tissue disease. in Mixed connective tissue diseases and antinuclear antibodies (eds Kasukawa, R. & Sharp, G. C.) 33–40 (Elsevier, 1987).

  • Lundberg, I. E. et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann. Rheum. Dis. 76, 1955–1964 (2017).

    PubMed PubMed Central Google Scholar

  • Damoiseaux, J. et al. Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective. Ann. Rheum. Dis. 78, 879–889 (2019).

    CAS PubMed PubMed Central Google Scholar

  • Chan, E. K. et al. Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014–2015. Front. Immunol. 6, 412 (2015).

    PubMed PubMed Central Google Scholar

  • Cavazzana, I. et al. Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. J. Immunol. Methods 474, 112661 (2019).

    CAS PubMed Google Scholar

  • Agmon-Levin, N. et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann. Rheum. Dis. 73, 17–23 (2014).

    CAS PubMed Google Scholar

  • Tan, E. M. et al. Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum. 40, 1601–1611 (1997).

    CAS PubMed Google Scholar

  • Leuchten, N. et al. Detection of antinuclear antibodies for classifying systemic lupus erythematosus: a systematic literature review and meta-regression of diagnostic data. Arthritis Care Res. 70, 428–438 (2018).

    CAS Google Scholar

  • Op De Beeck, K. et al. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun. Rev. 10, 801–808 (2011).

    CAS PubMed Google Scholar

  • Willems, P. et al. Screening for connective tissue disease-associated antibodies by automated immunoassay. Clin. Chem. Lab. Med. 56, 909–918 (2018).

    CAS PubMed Google Scholar

  • Willems, P. et al. Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities. Ann. Rheum. Dis. 78, e76 (2019).

    PubMed Google Scholar

  • Mariz, H. A. et al. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum. 63, 191–200 (2011).

    CAS PubMed Google Scholar

  • Vulsteke, J. B. et al. Titre-specific positive predictive value of antinuclear antibody patterns. Ann. Rheum. Dis. pii: annrheumdis-2019–216245 (2019).

  • Albesa, R. et al. Increased prevalence of anti-DFS70 antibodies in young females: experience from a large international multi-center study on blood donors. Clin. Chem. Lab. Med. 57, 999–1005 (2019).

    CAS PubMed Google Scholar

  • Conrad, K., Röber, N., Andrade, L. E. & Mahler, M. The clinical relevance of anti-DFS70 autoantibodies. Clin. Rev. Allergy Immunol. 52, 202–216 (2017).

    CAS PubMed Google Scholar

  • Mahler, M., Andrade, L. E., Casiano, C. A., Malyavantham, K. & Fritzler, M. J. Anti-DFS70 antibodies: an update on our current understanding and their clinical usefulness. Expert. Rev. Clin. Immunol. 15, 241–250 (2019).

    CAS PubMed Google Scholar

  • Bonroy, C. et al. The importance of detecting anti-DFS70 in routine clinical practice: comparison of different care settings. Clin. Chem. Lab. Med. 56, 1090–1099 (2018).

    CAS PubMed Google Scholar

  • Bossuyt, X. et al. Detection of antinuclear antibodies by automated indirect immunofluorescence analysis. Clin. Chim. Acta 415, 101–106 (2013).

    CAS PubMed Google Scholar

  • Claessens, J. et al. Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies. Autoimmun. Rev. 17, 533–540 (2018).

    CAS PubMed Google Scholar

  • Van Hoovels, L. et al. Analytical performance of the single well titer function of NOVA View®: good enough to omit ANA IIF titer analysis? Clin. Chem. Lab. Med. 56, 258–261 (2018).

    PubMed Google Scholar

  • Oyaert, M., Bossuyt, X., Ravelingien, I. & Van Hoovels, L. Added value of indirect immunofluorescence intensity of automated antinuclear antibody testing in a secondary hospital setting. Clin. Chem. Lab. Med. 54, e63–e66 (2016).

    CAS PubMed Google Scholar

  • Schouwers, S. et al. Value-added reporting of antinuclear antibody testing by automated indirect immunofluorescence analysis. Clin. Chem. Lab. Med. 52, 547–551 (2014).

    CAS PubMed Google Scholar

  • Bossuyt, X. et al. Harmonization of clinical interpretation of antinuclear antibody test results by solid phase assay and by indirect immunofluorescence through likelihood ratios. Autoimmun. Rev. 11, 102386 (2019).

    Google Scholar

  • Bossuyt, X. & Luyckx, A. Antibodies to extractable nuclear antigens in antinuclear antibody-negative samples. Clin. Chem. 51, 2426–2427 (2005).

    CAS PubMed Google Scholar

  • Hoffman, I. E. A., Peene, I., Veys, E. & De Keyser, F. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening test. Clin. Chem. 48, 2171–2176 (2002).

    CAS PubMed Google Scholar

  • Mahler, M. et al. International multicenter evaluation of autoantibodies to ribosomal P proteins. Clin. Vaccine Immunol. 13, 77–83 (2006).

    CAS PubMed PubMed Central Google Scholar

  • Fritzler, M. J., Choi, M. Y. & Mahler, M. The anti-nuclear antibody (ANA) test in the diagnosis of anti-synthetase syndrome and other autoimmune myopathies (AIM). J. Rheumatol. 45, 444–445 (2018).

    CAS PubMed Google Scholar

  • Ceribelli, A. et al. Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. Arthritis Res. Ther. 14, R97 (2012).

    CAS PubMed PubMed Central Google Scholar

  • Stuhlmüller, B., Schneider, U., González-González, J. B. & Feist, E. Disease specific autoantibodies in idiopathic inflammatory myopathies. Front. Neurol. 10, 4382019 (2019).

    Google Scholar

  • Pisetsky, D. S., Thompson, D. K., Wajdula, J., Diehl, A. & Sridharan, S. Variability in antinuclear antibody testing to assess patient eligibility for clinical trials of novel treatments for systemic lupus erythematosus. Arthritis Rheumatol. 71, 1534–1538 (2019).

    CAS PubMed Google Scholar

  • Pisetsky, D. S., Spencer, D. M., Lipsky, P. E. & Rovin, B. H. Assay variation in the detection of antinuclear antibodies in the sera of patients with established SLE. Ann. Rheum. Dis. 77, 911–913 (2018).

    CAS PubMed Google Scholar

  • Pregnolato, F., Borghi, M. O., Meroni, P. L. & Forum Interdisciplinare per la Ricerca sulle Malattie Autoimmuni (FIRMA) Study Group. Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: the positive experience of a national multicentre study. Ann. Rheum. Dis. 78, e50 (2019).

    PubMed Google Scholar

  • Pham, B. N., Albarede, S., Guyard, A., Burg, E. & Maisonneuve, P. Impact of external quality assessment on antinuclear antibody detection performance. Lupus. 14, 113–119 (2005).

    CAS PubMed Google Scholar

  • Van Blerk, M. et al. Current practices in antinuclear antibody testing: results from the Belgian External Quality Assessment Scheme. Clin. Chem. Lab. Med. 47, 102–108 (2009).

    PubMed Google Scholar

  • Van Hoovels, L., Schouwers, S., Van den Bremt, S. & Bossuyt, X. Variation in antinuclear antibody detection by automated indirect immunofluorescence analysis. Ann Rheum Dis. 78, e48 (2018).

    PubMed Google Scholar

  • van der Pol, P., Bakker-Jonges, L. E., Kuijpers, J. H. S. A. M. & Schreurs, M. W. J. Analytical and clinical comparison of two fully automated immunoassay systems for the detection of autoantibodies to extractable nuclear antigens. Clin. Chim. Acta. 476, 54–159 (2018).

    Google Scholar

  • Jeong, S. et al. Evaluation of an automated screening assay, compared to indirect immunofluorescence, an extractable nuclear antigen assay, and a line immunoassay in a large cohort of Asian patients with antinuclear antibody-associated rheumatoid diseases: a multicenter retrospective study. J. Immunol. Res. 2018, 9094217 (2018).

    PubMed PubMed Central Google Scholar

  • Robier, C., Amouzadeh-Ghadikolai, O., Stettin, M. & Reicht, G. Comparison of the clinical utility of the Elia CTD Screen to indirect immunofluorescence on HEp-2 cells. Clin. Chem. Lab. Med. 54, 365–370 (2016).

    Google Scholar

  • Otten, H. G. et al. Measurement of antinuclear antibodies and their fine specificities: time for a change in strategy? Clin. Exp. Rheumatol. 35, 462–470 (2017).

    PubMed Google Scholar

  • Bentow, C. et al. Clinical performance evaluation of a novel, automated chemiluminescent immunoassay, QUANTA Flash CTD Screen Plus. Immunol. Res. 61, 110–116 (2015).

    CAS PubMed Google Scholar

  • Bizzaro, N. et al. The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseases. Autoimmun. Rev. 17, 541–547 (2018).

    CAS PubMed Google Scholar

  • Op De Beéck, K. et al. Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmun. Rev. 12, 137–143 (2012).

    PubMed Google Scholar

  • de Almeida Brito, F. et al. Diagnostic Evaluation of ELISA and chemiluminescent assays as alternative screening tests to indirect immunofluorescence for the detection of antibodies to cellular antigens. Am. J. Clin. Pathol. 145, 323–331 (2016).

    PubMed Google Scholar

  • Orme, M. E., Andalucia, C., Sjölander, S. & Bossuyt, X. A hierarchical bivariate meta-analysis of diagnostic test accuracy to provide direct comparisons of immunoassays versus indirect immunofluorescence for initial screening of connective tissue diseases. Clin. Chem. Lab. Med. https://doi.org/10.1515/cclm-2020-0094 (2020).

  • Orme, M. E., Andalucia, C., Sjölander, S. & Bossuyt, X. A comparison of a fluorescence enzyme immunoassay versus indirect immunofluorescence for initial screening for connective tissue diseases: systematic literature review and meta-analysis of diagnostic test accuracy studies. Best. Pract. Res. Clin. Rheumatol. 32, 521–534 (2018).

    PubMed Google Scholar

  • Bossuyt, X. et al. Antinuclear antibodies by indirect immunofluorescence and solid phase assays. Ann. Rheum. Dis. 79, e65 (2019).

    PubMed Google Scholar

  • Bossuyt, X. & Fieuws, S. Detection of antinuclear antibodies: added value of solid phase assay? Ann. Rheum. Dis. 73, e10 (2014).

    PubMed Google Scholar

  • Meroni, P. L. et al. Unending story of the indirect immunofluorescence assay on HEp-2 cells: old problems and new solutions? Ann. Rheum. Dis. 78, e46 (2019).

    PubMed Google Scholar

  • Pisetsky, D. S., Spencer, D. M., Rovin, B. & Lipsky, P. E. Role of ANA testing in the classification of patients with systemic lupus erythematosus. Ann. Rheum. Dis. https://doi.org/10.1136/annrheumdis-2019-216259 (2019).

    Article PubMed Google Scholar

  • Pisetsky, D. S., Spencer, D. M., Lipsky, P. E. & Rovin, B. H. Response to ‘Antinuclear antibodies by indirect immunofluorescence and solid phase assays’ by Bossuyt et al. Ann. Rheum. Dis. 79, e66 (2019).

    PubMed Google Scholar

  • Bizzaro, N. Can solid-phase assays replace immunofluorescence for ANA screening? Ann. Rheum. Dis. 79, e32 (2018).

    PubMed Google Scholar

  • Pisetsky, D. S., Bossuyt, X. & Meroni, P. L. ANA as an entry criterion for the classification of SLE. Autoimmun. Rev. 18, 102400 (2019).

    CAS PubMed Google Scholar

  • Damoiseaux, J. et al. Autoantibodies in idiopathic inflammatory myopathies: clinical associations and laboratory evaluation by mono- and multispecific immunoassays. Autoimmun. Rev. 18, 293–305 (2019).

    CAS PubMed Google Scholar

  • Cavazzana, I. et al. Testing for myositis specific autoantibodies: comparison between line blot and immunoprecipitation assays in 57 myositis sera. J. Immunol. Methods 433, 1–5 (2016).

    CAS PubMed Google Scholar

  • Vulsteke, J. B. et al. Detection of myositis-specific antibodies. Ann. Rheum. Dis. 78, e7 (2019).

    PubMed Google Scholar

  • Platteel, A. C. M. et al. Frequencies and clinical associations of myositis-related antibodies in The Netherlands: a one-year survey of all Dutch patients. J. Transl Autoimmunity 2, 100013 (2019).

    Google Scholar

  • Infantino, M. et al. Combining immunofluorescence with immunoblot assay improves the specificity of autoantibody testing for myositis. Rheumatology 58, 1239–1244 (2019).

    CAS PubMed Google Scholar

  • Picard, C. et al. Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study. Immunol. Res. 64, 677–686 (2016).

    CAS PubMed Google Scholar

  • Kaji, K. et al. Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement. Arthritis Care Res. 66, 575–584 (2014).

    CAS Google Scholar

  • Hennes, E. M. et al. International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48, 169–176 (2008).

    PubMed Google Scholar

  • Alvarez, F. et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J. Hepatol. 31, 929–938 (1999).

    CAS PubMed Google Scholar

  • European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J. Hepatol. 67, 145–172 (2017).

    Google Scholar

  • Martini, A. et al. Toward new classification criteria for juvenile idiopathic arthritis: first steps, Pediatric Rheumatology International Trials Organization International Consensus. J. Rheumatol. 46, 190–197 (2019).

    PubMed Google Scholar

  • Fierz, W. & Bossuyt, X. Likelihood ratios as value proposition for diagnostic laboratory tests. J. Appl. Lab. Med. 5, 1061–1069 (2020).

    PubMed Google Scholar

  • Choi, B. C. Slopes of a receiver operating characteristic curve and likelihood ratios for a diagnostic test. Am. J. Epidemiol. 148, 1127–1132 (1998).

    CAS PubMed Google Scholar

  • Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases (2024)

    References

    Top Articles
    Latest Posts
    Recommended Articles
    Article information

    Author: Kimberely Baumbach CPA

    Last Updated:

    Views: 5827

    Rating: 4 / 5 (61 voted)

    Reviews: 92% of readers found this page helpful

    Author information

    Name: Kimberely Baumbach CPA

    Birthday: 1996-01-14

    Address: 8381 Boyce Course, Imeldachester, ND 74681

    Phone: +3571286597580

    Job: Product Banking Analyst

    Hobby: Cosplaying, Inline skating, Amateur radio, Baton twirling, Mountaineering, Flying, Archery

    Introduction: My name is Kimberely Baumbach CPA, I am a gorgeous, bright, charming, encouraging, zealous, lively, good person who loves writing and wants to share my knowledge and understanding with you.